SEC Form D private-offering filing

Caldera Therapeutics, Inc.

Name: Caldera Therapeutics, Inc. - new SEC Form D private-offering filing, Cambridge, MA
Published: 2026-01-21

A new SEC Form D private-offering notice from Cambridge, MA, a $37,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Caldera Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing CLD-423, a bispecific antibody targeting IL-23p19 and TL1A for inflammatory bowel disease

Filed 2026-01-21Filed to raise $37,500,000First money in 2026-01-08Raised so far $37,500,000HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified calderatx.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.